Zenicor signs agreement with two University Hospitals in the UK
Zenicor Medical Systems AB has signed an agreement with two university hospitals in Northamptonshire, UK, for the delivery of the Zenicor Solution with Zenicor One (thumb ECG) for arrhythmia investigations. The order value is GBP 60,000, equivalent to approximately SEK 800,000, marking an important step in Zenicor’s continued expansion in the UK market.
University Hospitals of Northamptonshire (UHN), including Kettering General Hospital and Northampton General Hospital, is implementing the Zenicor Solution with Zenicor One as the primary choice for arrhythmia investigations following a successful pilot study. The study demonstrated shorter waiting times, increased resource efficiency, and an improved patient experience, resulting in significant cost savings and reduced time to diagnosis.
“By incorporating Zenicor One in our investigation of arrhythmias in patients with palpitations, we have been able to reduce the need for 7-day Holter monitoring and save time. Additionally, patients prefer Zenicor One over wearing a monitor for a week. It is now the first choice for investigating patients who would previously have received an ILR (Implantable Loop Recorder) but are now first assessed with Zenicor One,” says Leanne Kelly, Principal Cardiac Physiologist and Head of Arrhythmia Investigations at University Hospitals of Northamptonshire.
These two university hospitals in Northamptonshire are responsible for the care of approximately one million residents in the region, making this agreement a representative example of the broader adoption of Zenicor One in similar healthcare environments. It also contributes to the goal of offering these services to the entire UK population of 56 million people.
“This agreement marks an important step in Zenicor’s growth in the UK. The positive results clearly demonstrate the value that Zenicor One brings in terms of more efficient diagnostics and cost savings for arrhythmia investigations. We look forward to leveraging these results and this reference to support further growth and increased adoption within the UK healthcare system,” says Kaisa Rahkala, General Manager at Zenicor Ltd in the UK.
About University Hospitals of Northamptonshire
The University Hospitals of Northamptonshire (UHN) Group is a collaboration between Kettering General Hospital (KGH) and Northampton General Hospital (NGH). The purpose is to improve patient care and ensure more equitable access to healthcare services for the one million residents of Northamptonshire.
For more information, visit: https://uhn.nhs.uk/University-Hospitals-of-Northamptonshire.aspx
About Zenicor Zenicor Medical Systems was founded in 2003 and is a leader in the development of systems and care pathways for arrhythmia diagnostics and stroke prevention using ECG. Zenicor collaborates with healthcare providers to develop an integrated and optimized care pathway for arrhythmia investigations, focusing on patient-centered care and efficient resource utilization.
Since January 2023, Zenicor has been certified according to the European Medical Device Regulation (MDR).
For more information, visit: www.zenicor.se
For further information, please contact:
Mats Palerius, CEO, Zenicor Medical Systems AB +46 8 442 68 60 mats.palerius@zenicor.se
High-resolution images for download: http://zenicor.se/pressmaterial
